{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:14:04Z","timestamp":1786115644545,"version":"build-2736575974"},"reference-count":29,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Oncol.","Current Oncology"],"abstract":"<jats:p>The 70-gene signature (70-GS; MammaPrint) assay is useful for prognosis assessment in HR+\/HER2\u2212 early breast cancer, but limited accessibility motivates development of noninvasive alternatives. We retrospectively enrolled 219 women with preoperative grayscale ultrasound and 70-GS results, including a development cohort (n = 125), an internal validation cohort (n = 53), and a temporally independent validation cohort (n = 41). Radiomic features were extracted from manually delineated ROIs using PyRadiomics, and a radiomics score was derived after LASSO selection. Candidate radiomics-only, clinicopathologic-only, and full clinicoradiomic models were explored. To reduce overfitting, we selected a parsimonious model combining the radiomics score and Ki67 as the primary model. The simplified model achieved AUCs of 0.878, 0.816, and 0.831 in the development, internal validation, and temporally independent validation cohorts, respectively. In 1000 bootstrap resamples, the optimism-corrected AUC was 0.872 and the corrected calibration slope was 0.953. Adding the radiomics score to a Ki67-only model significantly improved model fit (likelihood-ratio chi-square = 17.14, df = 1, p &lt; 0.001). An ultrasound radiomics and Ki67 model may provide a noninvasive reference for estimating MammaPrint risk categorization, but it should be considered only as a supportive adjunct and not as a replacement for genomic testing.<\/jats:p>","DOI":"10.3390\/curroncol33080464","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:02:19Z","timestamp":1785830539000},"page":"464","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Parsimonious Ultrasound Radiomics and Ki-67 Model for Estimating MammaPrint Risk Categorization in HR+\/HER2\u2212 Early Breast Cancer"],"prefix":"10.3390","volume":"33","author":[{"given":"Yuanjing","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsu","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0618-2381","authenticated-orcid":false,"given":"Qingli","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"ref_1","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMra0801289","article-title":"Gene-expression signatures in breast cancer","volume":"360","author":"Sotiriou","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"Dai","year":"2002","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1634\/theoncologist.2011-0048","article-title":"Breast medical oncologists\u2019 use of standard prognostic factors to predict a 21-gene recurrence score","volume":"16","author":"Kamal","year":"2011","journal-title":"Oncologist"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(21)00007-3","article-title":"70-gene signature as an aid for treatment decisions in early breast cancer: Updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age","volume":"22","author":"Piccart","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","article-title":"NCCN Guidelines\u00ae Insights: Breast Cancer, Version 4.2021","volume":"19","author":"Gradishar","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13058-024-01797-7","article-title":"Clinically relevant gene signatures provide independent prognostic information in older breast cancer patients","volume":"26","author":"Johansson","year":"2024","journal-title":"Breast Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12967-023-04523-7","article-title":"Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients","volume":"21","author":"Pan","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101719","DOI":"10.1016\/j.xcrm.2024.101719","article-title":"Radiomics in breast cancer: Current advances and future directions","volume":"5","author":"Qi","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1002\/mco2.722","article-title":"Radiogenomics: Bridging the gap between imaging and genomics for precision oncology","volume":"5","author":"He","year":"2024","journal-title":"MedComm"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.37015\/AUDT.2021.200052","article-title":"Ultrasound Radiomics in Breast Cancer\u2014A Literature Review","volume":"5","author":"Yi","year":"2021","journal-title":"Adv. Ultrasound Diagn. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-025-07727-1","article-title":"Machine learning prediction of pathological complete response to neoadjuvant chemotherapy with peritumoral breast tumor ultrasound radiomics: Compare with intratumoral radiomics and clinicopathologic predictors","volume":"212","author":"Yao","year":"2025","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wu, J., Li, Y.X., Gong, W., Li, Q., Han, X., and Zhang, T.T. (2025). Multi-modality radiomics diagnosis of breast cancer based on MRI, ultrasound and mammography. BMC Med. Imaging, 25.","DOI":"10.1186\/s12880-025-01767-1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e232554","DOI":"10.1148\/radiol.232554","article-title":"Combining Radiomics and Autoencoders to Distinguish Benign and Malignant Breast Tumors on US Images","volume":"312","author":"Magnuska","year":"2024","journal-title":"Radiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e222646","DOI":"10.1148\/radiol.222646","article-title":"Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers","volume":"308","author":"Ramtohul","year":"2023","journal-title":"Radiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.icte.2024.09.008","article-title":"Explainable AI (XAI) in image segmentation in medicine, industry, and beyond: A survey","volume":"10","author":"Tsai","year":"2024","journal-title":"ICT Express"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s41747-024-00529-y","article-title":"Image biomarkers and explainable AI: Handcrafted features versus deep learned features","volume":"8","author":"Rundo","year":"2024","journal-title":"Eur. Radiol. Exp."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"111389","DOI":"10.1016\/j.ejrad.2024.111389","article-title":"Explaining explainability: The role of XAI in medical imaging","volume":"173","author":"Abrantes","year":"2024","journal-title":"Eur. J. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40477-025-01025-8","article-title":"Diagnostic value of ultrasound radiomic features in differentiating benign and malignant breast lesions","volume":"28","author":"Gong","year":"2025","journal-title":"J. Ultrasound"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fan, W., Cui, H., Liu, X., Zhang, X., Fang, X., Wang, J., Qin, Z., Yang, X., Tian, J., and Zhang, L. (2025). Machine learning-based ultrasound radiomics for predicting risk of recurrence in breast cancer. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1542643"},{"key":"ref_25","unstructured":"National Bureau of Statistics of China (2026, July 26). Households\u2019 Income and Consumption Expenditure in 2023, Available online: https:\/\/www.stats.gov.cn\/english\/PressRelease\/202402\/t20240201_1947120.html."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014dealing with the diversity of breast cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41416-020-01247-z","article-title":"Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative","volume":"124","author":"Lebeau","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-015-3559-0","article-title":"Prognostic value of different cut-off levels of Ki-67 in breast cancer: A systematic review and meta-analysis of 64,196 patients","volume":"153","author":"Petrelli","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies\u2014improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/8\/464\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:12:35Z","timestamp":1785989555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/8\/464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["curroncol33080464"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33080464","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}